[go: up one dir, main page]

MA45461A - Forme cristalline de 9-aminométhyle substitués des composés de tetracycline et leur procédé de préparation - Google Patents

Forme cristalline de 9-aminométhyle substitués des composés de tetracycline et leur procédé de préparation

Info

Publication number
MA45461A
MA45461A MA045461A MA45461A MA45461A MA 45461 A MA45461 A MA 45461A MA 045461 A MA045461 A MA 045461A MA 45461 A MA45461 A MA 45461A MA 45461 A MA45461 A MA 45461A
Authority
MA
Morocco
Prior art keywords
aminomethyl
preparation process
crystalline form
tetracycline compounds
form substituted
Prior art date
Application number
MA045461A
Other languages
English (en)
Inventor
Mei Hong
Zhenhua Huang
Chen Jiang
Original Assignee
Kbp Biosciences Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kbp Biosciences Co Ltd filed Critical Kbp Biosciences Co Ltd
Publication of MA45461A publication Critical patent/MA45461A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54Spiro-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
MA045461A 2016-06-22 2017-06-22 Forme cristalline de 9-aminométhyle substitués des composés de tetracycline et leur procédé de préparation MA45461A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610457261 2016-06-22

Publications (1)

Publication Number Publication Date
MA45461A true MA45461A (fr) 2019-05-01

Family

ID=60783195

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045461A MA45461A (fr) 2016-06-22 2017-06-22 Forme cristalline de 9-aminométhyle substitués des composés de tetracycline et leur procédé de préparation

Country Status (21)

Country Link
US (1) US10633337B2 (fr)
EP (1) EP3476831B8 (fr)
JP (1) JP6883593B2 (fr)
KR (1) KR102205843B1 (fr)
CN (1) CN109563035B (fr)
AU (1) AU2017282891B2 (fr)
CA (1) CA3028014C (fr)
CL (1) CL2018003739A1 (fr)
CO (1) CO2019000513A2 (fr)
ES (1) ES2906885T3 (fr)
IL (1) IL263868B (fr)
MA (1) MA45461A (fr)
MX (1) MX381701B (fr)
MY (1) MY186900A (fr)
PE (1) PE20190810A1 (fr)
PH (1) PH12018502680A1 (fr)
RU (2) RU2764723C2 (fr)
SG (1) SG11201811499WA (fr)
TW (1) TWI656116B (fr)
WO (1) WO2017219994A1 (fr)
ZA (1) ZA201900274B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD962414S1 (en) 2020-02-28 2022-08-30 Beijing Xiaomi Mobile Software Co., Ltd Fan
AU2021288202A1 (en) * 2020-06-11 2022-12-08 Paratek Pharmaceuticals Inc. Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064728A2 (fr) * 2003-01-16 2004-08-05 Paratek Pharmaceuticals, Inc. Composes de tetracycline possedant des activites therapeutiques ciblees
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
US8252946B2 (en) * 2007-11-14 2012-08-28 Sandoz Ag Crystalline forms of tigecycline hydrochloride
US20110124893A1 (en) * 2008-01-23 2011-05-26 Sandoz Ag Antibiotic compounds
TW202021946A (zh) * 2008-05-19 2020-06-16 美商派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
WO2013013505A1 (fr) 2011-07-26 2013-01-31 山东亨利医药科技有限责任公司 Composé tétracycline substitué par 9-aminométhyle
CN102417465B (zh) * 2011-10-27 2014-03-12 宫宁瑞 替加环素新晶型及其制备方法

Also Published As

Publication number Publication date
PH12018502680A1 (en) 2019-10-14
KR102205843B1 (ko) 2021-01-22
EP3476831B1 (fr) 2021-11-17
BR112018076726A2 (pt) 2019-04-02
CA3028014A1 (fr) 2017-12-28
RU2022100160A (ru) 2022-03-16
MX2019000086A (es) 2019-05-02
CO2019000513A2 (es) 2019-04-30
KR20190024900A (ko) 2019-03-08
TW201800393A (zh) 2018-01-01
MX381701B (es) 2025-03-13
RU2019101248A3 (fr) 2020-07-22
RU2019101248A (ru) 2020-07-22
PE20190810A1 (es) 2019-06-13
IL263868B (en) 2022-08-01
JP6883593B2 (ja) 2021-06-09
MY186900A (en) 2021-08-26
CA3028014C (fr) 2021-09-07
US10633337B2 (en) 2020-04-28
WO2017219994A1 (fr) 2017-12-28
US20190241515A1 (en) 2019-08-08
SG11201811499WA (en) 2019-01-30
NZ749495A (en) 2020-12-18
ES2906885T3 (es) 2022-04-20
AU2017282891B2 (en) 2020-01-02
JP2019520363A (ja) 2019-07-18
EP3476831A1 (fr) 2019-05-01
CL2018003739A1 (es) 2019-04-05
EP3476831A4 (fr) 2019-11-27
EP3476831B8 (fr) 2021-12-29
ZA201900274B (en) 2020-05-27
CN109563035B (zh) 2021-07-20
IL263868A (en) 2019-01-31
AU2017282891A1 (en) 2019-01-17
CN109563035A (zh) 2019-04-02
RU2764723C2 (ru) 2022-01-19
TWI656116B (zh) 2019-04-11

Similar Documents

Publication Publication Date Title
EP3372606A4 (fr) Forme cristalline, procédé de préparation et intermédiaire d'un composé à cycle dihydropyridine
EP3470400A4 (fr) Forme cristalline de l'ozanimod, forme cristalline de son hydrochloride et son procédé de préparation
EP3398960A4 (fr) Procédé de préparation du sermaglutide
EP3546489A4 (fr) Polypropylène et son procédé de préparation
EP3380630A4 (fr) Procédé de préparation de jus non cariogène à libération d'énergie prolongée
EP3383436A4 (fr) Procédé amélioré de préparation de vert d'indocyanine
EP3412672A4 (fr) Forme cristalline a d'un agoniste de tlr7, son procédé de préparation et son utilisation
EP3327025A4 (fr) Forme a cristalline de rebaudioside d, et son procédé de préparation et son application
EP3502103A4 (fr) Forme cristalline, type de sel d'un dérivé de 2-hydro-pyrazole substitué et son procédé de préparation
EP2977448A4 (fr) Procédé de préparation de chondrocytes
EP3694499A4 (fr) Nouveau procédé de préparation de lifitegrast
FR3002733B1 (fr) Nouveau sel de l'abexinostat, forme cristalline associee,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP3500551A4 (fr) Procédé de préparation de biphényles substitués
EP3766869A4 (fr) Procédé simple de préparation d'avibactam
EP3504221A4 (fr) Nouveau procédé de préparation de corticostéroïdes
EP3395810A4 (fr) Cristaux d'un dérivé de quinazoline et leur procédé de préparation
EP3294310A4 (fr) Composition oléorésineuse en poudre hautement concentrée et procédé de préparation de cette composition
EP3377049A4 (fr) Formes cristallines de sels de tapentadol et leur procédé de préparation
EP3505525A4 (fr) Procédé de préparation de rubusoside
EP3461822A4 (fr) Forme cristalline de composé chimique, son procédé de préparation, sa composition et son application
MA45461A (fr) Forme cristalline de 9-aminométhyle substitués des composés de tetracycline et leur procédé de préparation
EP3395811A4 (fr) Cristaux de dérivé quinazoline et leur procédé de préparation
EP3311804A4 (fr) Procédé d'élaboration de microcapsules de type colloïdosome
EP3733651A4 (fr) Procédé de préparation de calcobutrol
MA48944A (fr) Forme cristalline de n-butyldéoxygalactonojirimycine